Exploration of SAR regarding glucose moiety in novel C-aryl glucoside inhibitors of SGLT2.

Article Details

Citation

Park EJ, Kong Y, Lee JS, Lee SH, Lee J

Exploration of SAR regarding glucose moiety in novel C-aryl glucoside inhibitors of SGLT2.

Bioorg Med Chem Lett. 2011 Jan 15;21(2):742-6. doi: 10.1016/j.bmcl.2010.11.115. Epub 2010 Dec 3.

PubMed ID
21193308 [ View in PubMed
]
Abstract

In order to investigate SAR regarding glucose moiety in novel C-aryl glucoside SGLT2 inhibitors containing a thiazole motif, a series of chemical modifications on glucose was conducted to explore potential utility as a suitable replacement of glucose per se. Among the compounds prepared, deshydroxy 29 (IC(50)=7.01nM) demonstrated the best in vitro inhibitory activity against SGLT2 in this series to date. But, none of the compounds were better than the parent molecule 5 (IC(50)=1.75nM).

DrugBank Data that Cites this Article

Binding Properties
DrugTargetPropertyMeasurementpHTemperature (°C)
DapagliflozinSodium/glucose cotransporter 2IC 50 (nM)0.49N/AN/ADetails